安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
SSAA09E2 是一种新型的 SARS-CoV (严重急性呼吸综合征冠状病毒)复制抑制剂,通过阻断 SARS-S 与 SARS-CoV 受体血管紧张素转换酶-2 (ACE2) 的早期相互作用发挥作用。
SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) [1].
[1]. Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496.
动态评分
0.0